Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial "ELAN"

Recruiting

Phase N/A Results N/A

Summary of Purpose

When to start anticoagulation in patients with an acute ischaemic stroke and atrial fibrillation (AF) is a relevant unanswered question in clinical practice. Direct oral anticoagulants (DOACs) are highly effective for secondary stroke prevention in these patients, but DOACs were never initiated <7 days after stroke onset in recent trials. The ELAN trial will determine the net benefit of early versus late...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 November 2017.

6 Nov 2017 7 Apr 2017 30 Aug 2021 31 Oct 2021 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

See All